Ico Site Rene Gauducheau

SaintHerblain 44805

0 studies enrolling now · 6 studies all time

What they study most

Advanced Solid Tumor, Advanced or Inoperable Gastric Cancer, Cancer of the Prostate, Esophageal Squamous Cell Carcinoma (ESCC), Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Hormone Sensitive Prostate Cancer, Metastatic Solid Tumor, Prostate Cancer, Solid Tumor, Solid Tumor, Adult

Studies at this site

• A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma — Running, not enrolling
• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
• Study of DF1001 in Patients With Advanced Solid Tumors — Completed
• BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors — Stopped early
• Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer — Completed
• A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma — Completed